Evidence map›Paper›PMID 39474054›Full record

ArticleInternational journal of cell biology2024

A Comparative Study on the Effects of Mesenchymal Stem Cells and Their Conditioned Medium on Caco-2 Cells as an In Vitro Model for Inflammatory Bowel Disease.

Naser Kalhor, Hoda Fazaeli, Faezeh Davoodi Asl, Azar Sheikholeslami, Seyed Jalal Eshagh Hoseini, Mohsen Sheykhhasan

Abstract read
In one paragraph

Article in International journal of cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Naser KalhorDepartment of Mesenchymal Stem Cells, Academic Center for Education, Culture, and Research (ACECR), Qom Branch, Qom, Iran.ORCID https://orcid.org/0000-0001-8870-8035
Hoda FazaeliDepartment of Mesenchymal Stem Cells, Academic Center for Education, Culture, and Research (ACECR), Qom Branch, Qom, Iran.ORCID https://orcid.org/0000-0003-4724-2106
Faezeh Davoodi AslDepartment of Mesenchymal Stem Cells, Academic Center for Education, Culture, and Research (ACECR), Qom Branch, Qom, Iran.ORCID https://orcid.org/0000-0001-7212-0843
Azar SheikholeslamiDepartment of Mesenchymal Stem Cells, Academic Center for Education, Culture, and Research (ACECR), Qom Branch, Qom, Iran.ORCID https://orcid.org/0000-0001-8277-6539
Seyed Jalal Eshagh HoseiniDepartment of Surgery, Qom University of Medical Science, Qom, Iran.ORCID https://orcid.org/0000-0003-3139-9512
Mohsen SheykhhasanDepartment of Mesenchymal Stem Cells, Academic Center for Education, Culture, and Research (ACECR), Qom Branch, Qom, Iran.ORCID https://orcid.org/0000-0002-2522-4292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent research indicates that mesenchymal stem cells (MSCs), known for their anti-inflammatory and anti-infectious properties, could be a promising alternative for treating inflammatory diseases such as inflammatory bowel disease (IBD). This study examined how MSCs and their derivatives, when cocultured with interleukin-1

Indexed as

adipose tissuebone marrowinflammatory bowel diseasesmenstrual bloodmesenchymal stem cells

Identifiers

PMID39474054
PMCPMC11519077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.